A significant shift in our drug policy has occurred, as the government announce the availability of psilocybin hallucinogens for therapeutic applications. Until now, these substances were strictly restricted, but a increasing body of evidence suggests they may offer aid for emotional illnesses like anxiety. The new policy represents a substantial s